iSOFT Wins Two Regional Contract Extensions in Spain

iSOFTiSOFT Spain has won two contracts worth a total of €1.35 million with the public healthcare services of Andalusia and the Balearic Islands, with both customers extending their current agreements with the company. The Andalusian healthcare service (SAS) has renewed its contract for maintenance at 16 hospitals for another year in a deal worth €750,000. In addition, the Balearic Islands healthcare service (IB-SALUT) has awarded iSOFT a €600,000 contract extension to roll out its e-prescription solution to all primary care centres and pharmacies in Mallorca and Menorca.

Andalusia
The contract extension with the SAS is for the support, development and preventative maintenance of a range of iSOFT applications at hospitals across Andalusia's regional healthcare service. The initial project was awarded in 2006 and this latest order brings the total value of the work to €2.25 million.

The contract covers 16 of the 28 hospitals operated by the SAS across the Andalusia region. Some hospitals have one iSOFT application while others have the full range. These include x‑HIS (patient management), e-HC (electronic patient record), x-GPC (clinical order management) and departmental solutions such as PAT-Win (pathology), x-UC (intensive care), x‑LOG (logistics), x-LAB (laboratory) and x-FARMA (pharmacy).

Antonio Castillo, iSOFT Spain’s Strategic Accounts Director, said: "This maintenance contract extension is very important for iSOFT and clearly demonstrates that we continue to provide a first-class service and innovative solutions for public hospitals in the Andalusia region."

Balearic Islands
The Balearic Islands healthcare service (IB-SALUT) has awarded iSOFT a €600,000 contract extension to roll out its e-prescription solution to all primary care centres and pharmacies in Mallorca and Menorca, following a successful, award-winning project in Ibiza and Formentera. The total value of this project is €1.7 million after iSOFT won an initial €1.1 million order in 2006.

The e-prescription solution eliminates paper and so saves time, avoids mistakes and improves the monitoring of treatment. It also provides prescribing rules, a recommended list of drugs and automation of payments.

Roll-out to the 43 primary care centres in Mallorca will be completed this month and in the five centres in Menorca by December. Ultimately, the solution will be installed at the 55 health centres and 411 pharmacies across the four Balearic Islands for a population of 1.2 million people.

The latest phase follows successful projects at seven primary care centres in Ibiza and Formentera. During the six-month pilot, the application was used for over 27,500 prescriptions out of nearly 34,500 prescriptions dispensed.

In March this year, the project won the Correo Farmacéutico magazine award for best technology initiative, having won in March of last year the ComputerWorld magazine award for its positive impact on the local population.

Antonio Castillo said: "We have worked very closely with IB-SALUT since 2004 in helping it develop an electronic patient record for primary care and improve services to the people of the Balearic Islands. We are the preferred supplier of primary care systems and our e-SIAP solution is installed at all IB-SALUT's primary care centres, so it is very gratifying to also participate in the e-prescription implementation, an innovative project led by IB-SALUT that will serve as model for other autonomous regions."

Related news articles:

About IBA Health Group
IBA Health Group Limited (ASX-IBA) is the largest specialist information technology company listed on the Australian Securities Exchange.

IBA builds software applications for healthcare. We work with healthcare professionals to design and build solutions that answer all of the difficult questions posed by today's care delivery challenges. Our solutions act as a catalyst for change, supporting the exchange of critical information across diverse care settings and participant organisations. We are the leader in the provision of advanced application solutions in modern healthcare economies around the world.

Today, over 13,000 provider organisations in 35 countries across five continents use IBA's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of our market and anticipation of evolving requirements. Our business is driven by the collective talent, experience and commitment of over 3,500 healthcare IT experts around the globe.

A global network of IBA subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result we offer our customers comprehensive knowledge of local market requirements, in terms of culture, language, working practice, healthcare regulation and organisational structure.

For more information on IBA Health, please visit the Company's website at www.ibahealth.com.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...